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Abstract: Introduction: Ostene® is a new synthetic bone hemostatic wax-
like inert and biocompatible material that dissolves within two days after 
application. Bone wax is a well- known topical hemostatic agent, easy to use, 
and its application is very simple. Wound healing is a complex biological 
process; Bone is a dynamic tissue that is continuously resorbed, renewed, 
and remodeled.  Materials and methods: Twenty domestic rabbits were 
divided into four groups (day 1, day 3, day 7, and day 14). Each rabbit was 
anaesthetized and three holes were drilled in the mandible: one was filled 
with Ostene®, another with bone wax, and the other was left unfilled as 
control. Sites of intervention were assessed by histopathology. Results 
and Discussion: Ostene® and bone wax showed osteoinductive property 
in bone healing with no inf lammatory reaction. Our study revealed new 
bone formation within 14 days in Ostene® group. After histopathological 
analysis and scoring was finished, analysis by SPSS 14 software showed a 
significant difference between the use of Ostene® and bone wax. Conclusion: 
Ostene® showed superiority over bone wax in bone healing, and it can be 
used in the same way as bone wax with no interference with bone healing and 
osteogenesis. Ostene® has no side effects following application.
Keywords: Bone hemostatic agents; ostene; bone wax; bone healing; alkylene oxide 
copolymers.
INTRODUCTION.
Bone is a biologically highly dynamic vascularized living tissue, 
constant undergoing adaptation to the mechanical and metabolic 
demand of the body by means of bone regeneration and repair, as 
a result of the balance between the activity of osteoblasts and 
osteoclasts.1-4
Bones are largely made up of an organic matrix (osteoid) and the 
calcium hydroxyapatite mineral, which gives the bones strength and 
hardness. It is continuously resorbed, renewed, and remodeled. These 
processes are carried out by several different types of bone cells that 
are regulated by a number of transcription factors, cytokines, and 
growth factors.5                                                                                           
Osteoblasts are mature cells that are actively mobile, located on 
the surface of bones. These cells synthesize, transport, and arrange 
many proteins of matrix and bone forming cells.5,6 Osteoclasts are 
multinucleated cells which are responsible for bone resorption. They 
are larger than osteoblasts and osteocytes.5,7                                                                                             
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The healing process of bone has three overlapping 
stages: inf lam-mation, bone production, and bone 
remodeling. Regeneration can occur by three different 
mechanisms: osteogenesis, which is formation of new 
bone from bone forming cells; osteoconduction, the 
physical property of the graft to serve as a scaffold 
for new bone growth; and osteoinduction, which is a 
process whereby one tissue, or product derived from it, 
causes a second undifferentiated tissue to differentiate 
into bone. Bone healing processes depend mostly on 
osteoinduction.8-10                                      
Ostene® is a new synthetic bone hemostatic wax 
like material made of water- soluble alkylene oxide 
copolymers (AOC). It is composed of a sterile mixture 
of hydrophilic, biocompatible copolymers derived 
from ethylene oxide and propylene oxide. It is an 
inert material and dissolves from the bone within 48 
hours after application and it is excreted from the body 
unchanged through renal clearance safely without 
metabolism.11-16
Ostene® is applied in a similar fashion as bone wax 
and to a thickness of 1-2mm; it does not cause infection, 
nor induce inf lammatory reactions, and it does not 
interfere with coagulation, nor with osseous union.14-18  
AOC have a long history of use in the medical and 
pharmaceutical field, its approved by the U.S Food 
and Drug Administration, it dissolves from the site of 
application faster than other materials, and it is also 
hypothesized that AOC permits faster bone healing 
than other resorbable hemostatic agents.19,20 Ostene® 
may be a better alternative to bone wax due to its water 
solubility.13,21 
Bone wax is a well-known topical hemostatic 
agent, composed of cera alba (beeswax) (88%) and 
isopropyl palmitate (12%), a palm oil-based emollient, 
moisturizer, and thickening and anti-static agent.22-25 
Bone wax is relatively easy to use, and its application 
is very simple. It is a non-absorbable hemostatic sealant 
and it functions as a mechanical tamponade to stop bone 
bleeding in patients undergoing thoracic, orthopedic, 
craniofacial and neurosurgery.26,27 
This study aims to evaluate and compare the effects 
of Ostene® and bone wax in the healing process of the 
mandibular bone of the rabbit.
MATERIALS AND METHODS.
Study design 
Twenty domestic rabbits were selected and divided 
into four groups according to sacrificing day: (day 1, day 
3, day 7, and day 14). 
Three holes were drilled in each rabbit s´ mandible, 
these holes filled with different materials: one filled with 
Ostene®, the other filled with bone wax, and the last one 
left unfilled, as a control.                                                       
Surgical protocol
All surgery was done under general anesthesia, each 
animal was injected intramuscularly in the thigh muscle 
with 40 mg/kg ketamine and 4mg/kg xylazine.26,28,29   
Ten minute after anesthesia, shaving and cleansing of 
the skin was performed, then under aseptic conditions, 
a 1 cm incision was made under the mandible, and the 
mandibular bone was exposed. 
Three holes were drilled with a 2mm spherical dental 
burr to assure a standardized defect with equal depth 
and the drilling was done under irrigation with normal 
saline, two holes in the right side the nearest one to the 
midline filled with Ostene® and the second one filled 
with bone wax, the other hole in the left side was left 
unfilled, as a control. Suturing was then performed 
using sterile synthetic absorbable, Vicryl suture size 2-0.
Histopathological study
At the day of sacrificing, each mandible was dissected 
and fixed in 10% neutral buffered formalin, followed by 
decalcification of the bone to complete processing for 
the preparation of slides and staining with hematoxylin 
eosin. The histopathological scoring used was that of 
Sultana and Solchagal30,31  with small modifications, as 
the follows:
A. Amount of granulation tissue:
1.Profound.    
2.Moderate.    
3.Scant.    
4.Absent.
B. Inflammatory infiltrate:
1.Plenty.    
2.Moderate.    
3.Few.   
4.Absent.
C. De novo formation of blood vessels:
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0.Absent.   
1.Present peripherally.  
2.Present centrally.   
3.Present centrally and peripherally.
D. Presence of osteoblasts:
0.Absent.    
1.Present peripherally.  
2.Present centrally.    
3.Present centrally and peripherally.
E. Presence of osteoclasts:
0.Absent.  
1.Present peripherally.   
2.Present centrally.    
3.Present centrally and peripherally.
Figure 1. Histopathological section of three groups.
A B C
A. Ostene®.  B. Bone wax. C. Control.
*:  p-value: ≤ 0.05
*:  p-value: ≤ 0.05
*:  p-value: ≤ 0.05
Periods Mean Ranks for control Mean Ranks for bone wax Mean Ranks for Ostene® p –value
Day 1 1.20 2.10 2.70 0.042*
Day 3 1.10 2.20 2.70 0.029*
Day 7 1.80 2.40 1.80 0.135
Day 14 2.70 2.30 1.00 0.010*
Periods Mean Ranks for Ostene® Mean Ranks for bone wax Mean Ranks for control p –value
Day 1 1.50 2.00 2.50 0.146
Day 3 2.90 1.90 1.20 0.021*
Day 7 2.00 1.40 2.60 0.050*
Day 14 Equal Equal Equal Equal
Periods Mean Ranks for Osten® Mean Ranks for bone wax Mean Ranks for control p –value
Day 1 2.80 2.10 1.10 0.014*
Day 3 2.70 2.10 1.20 0.022*
Day 7 2.70 1.60 1.70 0.128
Day 14 2.20 2.00 1.80 0.779
Table 1. Comparison of the inflammatory variable between the three groups using Friedman test.
Table 2. Comparison of the granulation tissue variable comparison variable between 
the three groups using Friedman test.
Table 3. Comparison of the Blood vessels variable comparison variable between
the three groups using Friedman test.
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*:  p-value: ≤ 0.05
*:  p-value: ≤ 0.05
Periods Mean Ranks for Ostene® Mean Ranks for bone wax Mean Ranks for control p –value
Day 1 2.80 1.60 1.60 0.018*
Day 3 2.90 1.70 1.40 0.015*
Day 7 2.70 2.00 1.30 0.030
Day 14 2.40 2.50 1.10 0.022
Periods Mean Ranks for Osten® Mean Ranks for bone wax Mean Ranks for control p –value
Day 1 2.40 1.80 1.80 0.368
Day 3 2.70 1.80 1.50 0.039*
Day 7 2.70 2.20 1.10 0.024*
Day 14 2.30 2.70 1.00 0.016*
Table 4 . Comparison of the Osteoblast variable comparison variable between 
the three groups using Friedman test.
Table 5 . Comparison of the Osteoclast variable comparison variable between 
the three groups using Friedman test
RESULTS.
 After all animals were sacrificed as scheduled, ana-
lysis of the differences between the three experimental 
groups with Friedman test was performed. (Tables 
1, 2, 3, 4 and 5) In the Ostene® group enhance bone 
healing was apparent at 14 days illustrated by woven 
bone during this period. Abundance of bone trabeculae 
can be seen in histopathological section with a great 
amount of granulation tissue. (Figure 1A, Table 2) 
For the control group, normal bone healing occurred 
as expected during the healing period. Regarding the 
bone wax group, healing occurred to a lesser degree 
than in Ostene® group, granulation tissue and bone 
trabeculae was found in histopathological section but 
in lesser amounts compared to the Ostene® group. 
(Table 2) 
DISCUSSION.
Ostene® appears to have many advantages over bone 
wax as it did not cause inf lammation in excess while 
bone wax did. Furthermore Ostene® is removed from 
the body unchanged while bone wax is not. Our results 
are in agreement with  Gurcan et al.,23 who showed 
that the advantages of Ostene® over bone wax is that 
Ostene® is absorbed within two days, in addition to 
that it does not have adverse effects on healing and 
is excreted unchanged by the body. Nooh et al.,27 
informed a foreign body reaction to bone wax in the 
form of granulomatous inf lammation and fibrous 
encapsulation with the inhibition of bone healing and 
osteogenesis. In addition, Vestergaard et al.,32 showed 
that bone wax significantly inhibits bone healing and 
induces chronic inf lammation in pigs whereas Ostene® 
did not.                                                                                
About granulation tissue, there is a significant diffe-
rence in most of the groups but it is more marked in the 
Ostene® group, which may be due to Ostene® dissolving 
from the site of application within two days, allowing 
the early phases of bone healing to occur. 
This is in agreement with Wellisz et al.,11 who 
showed that the polymer material dissolved from the 
site of application within 24 to 48 hours allowing early 
bone healing to occur.                                                                                             
It is reported in Wellisz et al.,18 that bone wax 
increased infection rates and impaired the ability of 
bone to clear bacteria. Also this study revealed that bone 
wax remain as a foreign body at the site of application, 
and osteoblasts in bone wax group have been shown to 
be absent in the presence of a thin layer of bone wax. 
Our study revealed new bone formation (woven bone) 
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within 14 days in the Ostene® group, in agreement with 
Wellisz et al.,11 who showed that new bone grew within 
10 days in a rat femur defect treated with polymer and 
untreated controls.     
Bone wax is insoluble and therefore not resorbable, 
and it interferes with bone healing at the site of 
application, it may aid in the development of infection 
by decreasing bacterial clearance in the cancellous bone 
and inhibits osteoblasts from reaching bony defects, 
leading to impaired bone healing, whereas Ostene® 
does not cause infection, inf lammatory reactions, or 
interference in the osseous union.14,21
Both Wellisz et al.,18 and Wellisz et al.,20 found that, 
although bone wax was effective in stopping bone 
healing, it remains at the site of application and has a 
number of adverse effects, forming a physical barrier 
to bone healing. All the defects filled with Ostene® 
showed newly woven bone rich in cellular activity, with 
no evidence of fibrotic scar tissue, indicating that good 
healing occurred with an absence of fibrotic scar tissue. 
This revealed that Ostene® has an anti-fibrosis effect in 
agreement with results from other studies.19,23
Regarding the histopathological analysis, abundant, 
poorly organized bony trabeculae with maturation 
of granulation tissue into the connective tissue was 
observed the control group during 2nd week; while at 
the same period in the Ostene® group more organized 
granulation tissue with bone trabeculae which increased 
in number, thickness and organization was visible, in 
contrast to bone wax group who displayed less bone 
trabeculae in a disorganized manner, a phenomenon 
corroborated by other studies.12 
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